Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery
Natera, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $218.81
+14% in 7d after detection
Post-detection moves
1h
—
1d
+4.5%
3d
+3.6%
7d
+14%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS